AstraZeneca’s Lynparza shows promising results in phase 3 ovarian cancer trial
AstraZeneca has reported significant findings from its phase 3 trial, SOLO-2, for its ovarian cancer drug Lynparza (olaparib), demonstrating considerable improvement in survival chances for ... Read More
Genetic Breast Cancer : Causes, Symptoms and Treatment with New Drug Therapy
What is meant by Breast Cancer? Who gets Breast Cancer Mostly? Breast cancer is a cancerous growth deep in the breast tissue. It is most ... Read More